BackChinook Therapeutics Overview

Chinook Therapeutics Cost of Revenue

Cost of Revenue analysis for KDNY.

Quarterly Cost of Revenue

$433000.00
0.93% YoY

As of Jun 30, 2023

Annual Cost of Revenue (TTM)

$1.73M
302.33% YoY

Trailing 12 months ending Jun 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)